Read on for our top picks of the best Cash App stocks under 10 dollars.
Cash App is a quick, easy, and secure way to send and receive money.
When it was first launched, you could only use Cash App to pay for goods and services or transfer money to friends and family.
However, in 2019 Cash App added a feature where you can buy stocks directly from the app, which stacks up well compared with other more established online brokers.
This trading platform is very straightforward to use and can be a game-changer within the digital investing community.
We’ve rounded up a list of the top stocks under $10 on Cash App to help you get started.
Best Cash App Stocks Under 10 Dollars
Bitfarms Ltd. (NASDAQ: BITF)
Bitfarms Ltd. (BITF) is a Canadian crypto mining company that operates four farms in Quebec.
Founded in 2013 by Nicolas Bouthillier and Martin Tremblay, Bitfarms began as a bitcoin exchange but soon shifted its focus to bitcoin mining.
The location of its farms is significant because Quebec has some of the lowest electricity rates in North America.
The company’s first farm was launched in 2014, and the fourth farm was established in early 2018.
Bitfarms is one of the largest bitcoin miners in the world.
The company recently announced that for the first 11 months of 2021, it was able to mine 3,000 Bitcoin valued at $175 million at current market prices.
Its latest earnings report showed growth in revenue of $44.8 million from $6.8 million last year.
Bitfarms Ltd. also reported record profitability of $23.7 million, up from a net loss of $4.8 Million from last year.
Overall, the company is in constant expansion mode with plans to launch new farms soon.
If you want to jump on the bitcoin bus, Bitfarms could be your ticket.
Aptinyx (NASDAQ: APTX)
Aptinyx (APTX) is a clinical-stage biopharmaceutical company that is researching and developing novel therapies for brain diseases and disorders.
The company’s lead product candidate is NYX-2925, which is an orally available NMDA receptor modulator that is currently in Phase 2b clinical development for the treatment of fibromyalgia and neuropathic pain.
Patients with painful diabetic peripheral neuropathy who had completed enrollment in Phase 2b of the NYX-2925 study are eligible to participate.
The findings are expected in the early to mid-second quarter of 2022.
Aptinyx is also developing NYX-783, a novel small molecule that has shown promising preclinical results in reversing Post-Traumatic Stress Disorder.
NYX-783 is currently in Phase 2 of clinical testing.
With plans on continuing its development throughout its portfolio, the company secured a capital credit facility of up to $50m from K2 HealthVentures.
This will help give Aptinyx that extra amount of funding to continue the development of its pipeline.
Shares are currently trading under $10 on Cash App with a market cap of more than $190 million.
Electra Meccanica Vehicles (NASDAQ: SOLO)
Electra Meccanica Vehicles Corp. Ltd. (NASDAQ: SOLO) is a Canadian company that designs, manufactures, and sells electric vehicles.
The company was founded in 2007 by Jerry Kroll and Ian Clifford.
The company’s first vehicle, the SOLO, is a three-wheeled electric vehicle designed for urban commuters.
The SOLO has a top speed of 80 mph and a range of 100 miles.
The vehicle is available in two versions: the standard SOLO and the SOLO Sport.
The company produced and sold 182 SOLO EVs since August 2020.
It also announced its partnership with Bosch, a leading industrial tech company that will support SOLO’s maintenance and service operation.
In addition, the company is in discussion with several potential distribution partners to ramp up SOLO’s production and distribution.
Electra Meccanica has a team of engineers and designers working on its new line of vehicles: the CARGO, which is an all-electric pickup truck that debuted in Advanced Clean Transportation (ACT) Expo 2021.
Given its experience in the EV market and continued commercial success of its first EV, SOLO could be a highly lucrative investment in the growing electric vehicles market.
Muscle Maker Inc. (NASDAQ: GRIL)
Muscle Maker Inc. is a healthy fast-food chain that serves delicious and nutritious meals without guilt.
The company has a strong presence in the Northeast, with locations in New Jersey, Pennsylvania, and Connecticut.
Muscle Maker first hit the scene in 1995 and has grown ever since.
The company went public in 2015 and is listed on the NASDAQ under the ticker GRIL.
Muscle Maker specializes in making healthy versions of popular fast-food items like burgers, chicken sandwiches, and pizza.
Aside from its healthy line of products, investors admire its growth over the past months despite a rough patch they experienced during the early months of the pandemic.
The company announced a 190% revenue increase with the integration of recent purchases.
In addition, its restaurant-level operating margins have been increasing steadily since last year and currently sit at around 21%.
Its most recent franchise agreement totaled 35 huge signings over the last two months, boosting its overall growth to 238% since May 2021.
Muscle Maker is a decent and low-priced stock, but its investment potential doesn’t justify its share price.
So if you are looking for a solid growth stock trading under $10, Muscle Maker Inc. might be a perfect choice.
Ready to build your portfolio? With Public.com you can follow other investors, discover companies that are inline with your beliefs, and invest into stocks and crypto with very little money! What are you waiting for? Check out Public Now!
Top Cash App Stocks Under $10
Inuvo Inc. (NYSE: INUV)
Inuvo, Inc. (NYSE: INUV) is a technology company that operates in the digital advertising and marketing industries.
The company’s products and services include providing website publishers with monetization tools to sell ads directly to brands and agencies, as well as helping marketers identify and reach their target audiences across the internet.
Inuvo’s customers include some of the world’s largest brands and agencies.
The company has a market capitalization of just over $65 million and an enterprise value of around $88 million.
Inuvo reported revenue of $16.8 million for the third quarter, up 83% year after year and 33% sequentially.
The company’s platforms continue to exceed expectations and have offered an attractive return on their investment profile compared to last year’s results.
By September 30, 2021, they had surpassed the previous quarter’s revenues by 71% for IntentKey and 88% for ValidClick.
Spending on digital advertising rises during the coronavirus epidemic.
Companies plan to invest in AI technologies to improve their outcomes, which may benefit Inuvo, Inc. (NYSE: INUV) stock in future years.
Given its low valuation and rising interest rates e, Inuvo, Inc. (NYSE: INUV) stock may provide investors with an excellent opportunity to invest in the advertising sector.
Celularity Inc. (NASDAQ: CELU)
Celularity Inc. (NASDAQ: CELU) is a biotechnology company focused on producing allogeneic T cell medications.
Allogeneic tissues and cells derived from umbilical cords and postpartum placentas produced by the company are used to develop life-changing therapies for various diseases, including Crohn’s disease and cancer.
It is based in New Jersey and focuses on the BioBanking, Degenerative disease, and Cell therapy markets.
The FDA has just granted Fast Track Designation to the company’s CYNK-001 drug, which is being studied for treating acute myeloid leukemia.
By completing the steps at this stage, the company will be one step closer to approval, which will benefit patients with this indication while also bringing in more investors.
Additionally, Celularity recently announced collaborations with two other companies to commercialize disease-fighting therapeutics to treat Acute Myeloid Leukemia (AML) and Parkinson’s Disease.
CELU can potentially reap significant profits for investors if its clinical trials go well for CYNK-001 and become commercially available.
Overall, Celularity Inc. is a leading biotech play with the potential to generate significant returns for investors once it gets FDA approval.
Asensus Surgical Inc. (NYSE: ASXC)
Asensus Surgical Inc. (NYSE: ASXC) is a medical device company that develops, manufactures, and markets surgical products for general surgery, gynecology, and other medical specialties.
The company’s product offerings include the Sehance Surgical System, Asensus Laparoscopic System, the Asensus Gynecologic System, and the Asensus Thoracic System.
The company’s products perform a variety of surgical procedures, including laparoscopic, hysteroscopic, thoracoscopic, and general surgery procedures.
Asensus Surgical Inc. reported that its third-quarter earnings increased to $14.3 million or $0.12 per share from $11.9 million or $0.06 per share last year.
The company’s revenue for the quarter also increased to $2.6 million from about $0.8 million during the same time last year.
In addition, Senhance® Surgical Systems performed a record number of procedures in the first quarter, increasing by 47% every year.
The company also plans to expand its distribution network in the United States through resellers, distributors, and representatives to help the company achieve its goals.
With all this news, it could be an excellent opportunity to invest here, as the future of this company is very encouraging.
Ontrak, Inc. (NASDAQ: OTRK)
Ontrak, Inc. (NASDAQ: OTRK) Ontrak, Inc. is an artificial intelligence-powered telehealth healthcare company.
It focuses on individuals with depression, anxiety, and other mood disorders through personalized care coaching pathways.
The Care Coach is an AI technology that provides care coaching, enabling members to engage with their medical providers through an integrated intervention platform.
The company’s integrated intervention platform combines artificial intelligence, predictive analytics, and digital interfaces with hundreds of care coach interactions to produce better member health, greater healthcare system use, and long-term benefits and savings for insurance companies.
Its latest financial reports revealed the growth and progression in its sales pipeline, together with three US major health plan providers.
Total gross profit for the third quarter of 2021 was $12.7 million, up from $10.9 million from last year, resulting in a revenue boost of $18.6 million and adjusted EBITDA of $1.7 million compared to adjusted EBITDA of $0.8 million in 2020.
With all this said, Ontrak has a lot of potential to grow exponentially as the AI industry takes off.
Most Popular Cash App Stocks Under 10 Dollars
CPI Aerostructures Inc. (NYSE: CVU)
CPI Aerostructures Inc. is a firm that specializes in the production of structural sub-assemblies and airplane parts for fixed-wing aircraft and helicopters.
The firm is committed to providing high-quality services to the aerospace and military industries.
Customer support is increasingly reliant on technology and innovation to deliver higher-quality solutions.
Currently, it provides construction services for commercial contractors and military contractors and is officially a US Department of Defense subcontractor.
The firm has recently reported its latest financial results, which display significant increases in revenue and earnings.
It detailed a revenue growth of $30.8 million compared to $16.9 million and an increased profit of $4.9 million compared to $0.2 million.
The company’s execution of its funded military backlog aided revenue growth, with military contracts bringing in more than $28.9 million, compared to less than $1.9 million from commercial aviation contracts.
A $4.6 million swing to bottom-line profitability was generated by the combination of a better gross margin and decreased interest expense, somewhat offset by higher SGA costs.
The company’s financial goal is to improve its balance sheet, increase profit margins, and create new opportunities to optimize the mix of products.
If you’re looking to invest in equities but are new to trading, you might want to consider CPI Aerostructures Inc.
The company is profitable and has proliferated over the past year with no current debt.
It also pays a dividend.
Genius Sports Limited (NYSE: GENI)
Genius Sports Limited (NYSE: GENI) is a global sports data and technology company.
The company’s core business is supplying sports data and information services to the global sports industry, including betting operators, broadcasters, commercial partners, and regulatory bodies.
GENIUS SPORTS offers a range of services, including live data feeds, sports content and editorial, betting services, integrity services, and consulting.
The Company operates through Sports Data and Technology and Betting Solutions.
Its share price jumped recently after it reported its quarterly earnings report.
The company gained a record revenue of $69.1 million, a whopping 70% year-over-year growth.
This was due to its ongoing partnerships with different betting companies worldwide.
Its Q3 partnerships include Caesars, DraftKings, Hardrock Digital, and WynnBet, to name a few.
Finally, over 97% of the market in the United States now uses NFL data exclusively through Genius.
Given its record numbers, soaring share price, and a long list of betting companies on the continuation of its partnerships, the future looks promising for Genius.
Ocean Bio-Chem, Inc. (NASDAQ: OBCI)
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) is a company that engages in the manufacture, distribution, and sale of marine and automotive products in the U.S.
The company offers a diversified line of products that includes fuel additives and treatments, appearance products, boat care products, engine treatment products, and other specialty items.
Its products are used by recreational boaters, fishers, watercraft owners, automotive enthusiasts, and others.
Ocean Bio-Chem’s latest financial report showed that it generated $21.5 million in net sales during the fiscal year ending September 30, 2021.
Despite material shortages, increased freight, inflated raw material costs, and even some major raw chemical suppliers invoking Force Majeure, it managed to boost sales on all of its product lines.
As a result, many of its major clients — including brick and mortar, online, and distribution partners — have rewarded Ocean Bio-chem with industry-leading sales gains of 18% over the company’s record-breaking 2020 year-to-date sales.
OBCI is currently one of the fastest-growing biotech companies with stocks under ten bucks on Cash App.
Should You Buy $10 Stocks on Cash App?
Whether you want to invest in low-priced stocks under $10 or blue-chip companies, Cash App is a great place to start.
It provides an excellent opportunity for everyone — regardless of your experience, age, or investment goals.
Some people might be hesitant to invest in stocks because of the risks involved.
But with Cash App, you can start small and gradually increase your investment as you get more comfortable with the process.
Aside from the convenience of investing on your phone, Cash App provides a wealth of information on its website.
Stocks under $10 usually represent up-and-coming companies that could have a lot of room to grow, and with just a handful of bucks, you can get a piece of the action.
Most of these companies are listed on the NASDAQ and New York Stock Exchange (NYSE), so they could be less risky than OTC stocks.
Can You Trust Cash App?
Cash App is a trusted platform for investing.
Cash App Investing has received positive reviews in both app stores.
Apple users give it a rating of 4.7 stars out of 5, while Android users give it a rating of 4.2 of 5.
You have the option of linking your bank account to the app or simply using your current Cash App balance to fill your account.
After that, you may choose an investment to purchase, input the amount you wish to invest, and complete the transaction.
You can sell your assets and withdraw your funds at any time, depending on how you funded your account.
Cash App has positioned itself as a great alternative to more complex trading platforms with its low fees and easy-to-use interface.
When using the Cash App investing feature, you can diversify your portfolio by putting money into different portfolios and performing other activities like transferring funds between your bank account and your Cash App.
You can do all of this from the convenience of your mobile device.
Cash App Stocks Under 10 Bucks: Final Thoughts
Whether you’re looking for new investments or want some extra cash on hand, trading stocks under $10 on Cash App could be the way to go.
Cash App has thousands of stocks to choose from, so there is sure to be something for everyone!
The best part about Cash App is that funds are released in two business days.
This is great for people who need an immediate return on their investment.
And Cash App is a great place to start looking.
It’s never too late and never too early to invest.
Cash App Stocks Under $10 FAQ
Take a look at our answers to the most commonly asked questions about Cash App.
Is Cash App Good for Stocks?
Cash app is a great platform for buying and selling stocks.
However, its selection is limited compared to other platforms.
Are There Penny Stocks on Cash App?
There are penny stocks on Cash App, which are stocks that trade for less than $5.
Can You Start Stocks with 10 Dollars?
Yes, you can start trading with stocks that are 10 dollars.
This price range offers a good balance of volatility as well as companies that are bound to a higher degree of transparency.
These are generally more predictable than cheap stocks that trade in the penny stock range.
What Is the Best Stock to Buy on Cash App?
The first pick on our list, Bitfarms Ltd. (NASDAQ: BITF) has a solid business model and is strategically placed to lower its operating costs.
There are plenty of winners on the stock market, and the “best” really depends on the needs of your portfolio.